@00:40
Our Mission
We established the Young Blood Institute to advance new uses for well established blood plasma replacement therapies, historically used to naturally restore our body's immune system, which demonstrate potential to significantly mitigate or prevent many age-associated disease conditions as well as rejuvenate our body's stem cells. Our program only employs fully licensed physician sub-specialists (Transfusion Medicine and Immunology) and nurses. We administer therapies according to widely accepted evidenced based medicine guidelines established by the American Society For Apheresis (ASFA).
Our Studies
Our studies of Heterochronic Plasma Exchange (HPE) – the replacement of aged plasma with young plasma components – began in 2018 and will continue over the next 2-3 years, or the first 1,000 patients, whichever comes first. Qualifying study subjects must be individuals 30 years or older and have 2 or more age-related conditions (senescence phenotypic factors) and/or an immunologic or inflammatory abnormality. We may exclude individuals with poor peripheral vascular access, diagnosis of malignancy, late stage Alzheimer’s disease, a positive pregnancy test in woman, and any medical condition that may deteriorate during plasma exchange procedures.
https://youngbloodinstitute.org/our-program.html